Browsing Tag
compounding pharmacies
2 posts
HIMS near 52-week low as FDA issues 30 GLP-1 warning letters
FDA sends 30 warning letters to GLP-1 compounders, targeting Hims & Hers Health (HIMS) as regulatory and legal pressure intensifies. Read what it means for investors and the sector.
March 4, 2026
Inside the Pete Pharma–FABRX deal: Can 3D printing finally scale in compounding pharmacies?
Pete Pharma partners with FABRX to bring 3D printing to U.S. compounding pharmacies—find out how this could transform personalized medication delivery.
September 13, 2025